Keywords: دوکسوروبیسین; Caco-2 cells; Doxorubicin; Surfactants; In vivo; Rats; P-gp; Inhibitor
مقالات ISI دوکسوروبیسین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دوکسوروبیسین; Doxorubicin; Monoamines metabolism; HPLC; Rat brain structures
Keywords: دوکسوروبیسین; Doxorubicin; Doxorubicin's dipeptide prodrug; HPLC–FD; Mice plasma
Keywords: دوکسوروبیسین; Doxorubicin; Magnetic nanoparticles; Protein; Fluorescence spectroscopy
Keywords: دوکسوروبیسین; Apoptosis; Cardioprotective; Doxorubicin; H9c2; Lipid peroxidation; Reactive oxygen species
Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release
Keywords: دوکسوروبیسین; PAMAM; Heparin; Cancer therapy; Dendrimer; Doxorubicin; Controlled release; Drug delivery system;
Near-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7/ADR cells
Keywords: دوکسوروبیسین; Doxorubicin; Quercetin; Synergistic; Gold nanocages; Multidrug resistance;
Synthesis, characterization and biological evaluation of purine nucleoside analogues
Keywords: دوکسوروبیسین; Cytotoxicity; Doxorubicin; Purine nucleosides; Sonogashira coupling;
Pegylated liposomal doxorubicin (Caelyx®) interference with the spectrophotometric Jaffe method for quantitative determination of creatinine in human plasma
Keywords: دوکسوروبیسین; Creatinine; Jaffe; Caelyx; Doxorubicin; Interference;
Chemotherapy alters cisatracurium induced neuromuscular blockade characteristics: A prospective cohort study
Keywords: دوکسوروبیسین; General anesthesia; Cisatracurium; Chemotherapy; Neuromuscular blocking agents; Doxorubicin;
Data on the anti-tumor effects of Selaginella tamariscina extract and amentoflavone combined with doxorubicin in mice
Keywords: دوکسوروبیسین; Amentoflavone; Anti-tumor; Doxorubicin; Selaginella tamariscina;
Cytogenotoxicological defense of retinyl palmitate in the front damage of antineoplastics
Keywords: دوکسوروبیسین; Doxorubicin; Cyclophosphamide; Toxicogenetic effects; Retinyl palmitate;
A general strategy to facilely design ratiometric electrochemical sensors in electrolyte solution by directly using a bare electrode for dual-signal sensing of analytes
Keywords: دوکسوروبیسین; Electrochemical sensors; Ratiometric; Doxorubicin; Bare electrode; Electrolyte solution;
Synergistic effects of 15-deoxy Î12,14-prostaglandin J2 on the anti-tumor activity of doxorubicin in renal cell carcinoma
Keywords: دوکسوروبیسین; Renal cell carcinoma; 15-deoxy Î12,14-prostaglandin J2; Doxorubicin; Phosphoinositide 3-kinase; Chemoresistant;
Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas
Keywords: دوکسوروبیسین; Olaratumab; PDGFR-α; Soft tissue sarcomas; Doxorubicin;
Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients
Keywords: دوکسوروبیسین; Breast; Cancer; Adjuvant chemotherapy; Elderly; Non-pegylated; Liposomal; Doxorubicin; Cyclophosphamide; Paclitaxel;
Pharmacokinetics of a liposomal formulation of doxorubicin in rats
Keywords: دوکسوروبیسین; Pharmacokinetics; Doxorubicin; Liposomes; Solid-phase extraction;
Protective effects of agmatine on doxorubicin-induced chronic cardiotoxicity in rat
Keywords: دوکسوروبیسین; Doxorubicin; Agmatine; Papillary muscle; Cardiotoxicity; ECG; Rats;
Efficacious cellular codelivery of doxorubicin and EGFP siRNA mediated by the composition of PLGA and PEI protected gold nanoparticles
Keywords: دوکسوروبیسین; Codelivery; Doxorubicin; siRNA; PLGA; PEI gold nanoparticles;
Simultaneous hyperthermia and doxorubicin delivery from polymer-coated magnetite nanoparticles
Keywords: دوکسوروبیسین; Doxorubicin; Drug release; Magnetic hyperthermia; Magnetic nanoparticles; Polymeric stabilization; PEGylation;
Generation of recombinant protein shells of Johnson grass chlorotic stripe mosaic virus in tobacco plants and their use as drug carrier
Keywords: دوکسوروبیسین; Virus-like particles; Doxorubicin; Drug delivery; Nanoparticles;
Short-term and long-term models of doxorubicin-induced cardiomyopathy in rats: A comparison of functional and histopathological changes
Keywords: دوکسوروبیسین; DCM; dilated cardiomyopathy; DXR; doxorubicin; HF; heart failure, ST group short-term doxorubicin injection; LT group; long-term doxorubicin injection; LV; left ventricle, LVEF left ventricle ejection function; LVDd; LV end-diastolic dimension; LVDs; end-
Targeted superparamagnetic nanoparticles coated with 2-deoxy-d-gloucose and doxorubicin more sensitize breast cancer cells to ionizing radiation
Keywords: دوکسوروبیسین; 2-Deoxy-d-Glucose; Breast cancer; Chemotherapy; Doxorubicin; Nanocomposite; Ionizing radiation; 2DG; Two-Deoxy-d-Glucose; ATP; Adenosine triphosphate; CT; Computed tomography; DOX; Doxorubicin; HA; hydroxyapatite; MNP; Magnetic nanoparticle; MRI; Magnetic
Synergistic antitumor effect of histone deacetylase inhibitor and Doxorubicin in peripheral T-cell lymphoma
Keywords: دوکسوروبیسین; Chidamide; Doxorubicin; PTCL; Synergistic antitumor effect;
Ameliorative effects of sildenafil and/or febuxostat on doxorubicin-induced nephrotoxicity in rats
Keywords: دوکسوروبیسین; Doxorubicin; Adriamycin; (PubChem CID: 31703); Sildenafil citrate (PubChem CID: 62853); Febuxostat (PubChem CID: 134018); Nephrotoxicity; Doxorubicin; Sildenafil; Febuxostat; Oxidative stress; Antiinflammatory;
Mesoporous hydroxyapatite nanoparticles hydrothermally synthesized in aqueous solution with hexametaphosphate and tea polyphenols
Keywords: دوکسوروبیسین; Mesoporous; Hydroxyapatite; Doxorubicin; Hexametaphosphate; Tea polyphenols;
Microbial biosensors to monitor the encapsulation effectiveness of Doxorubicin in chimeric advanced Drug Delivery Nano Systems: A calorimetric approach
Keywords: دوکسوروبیسین; chi-aDDnS; chimeric advanced Drug Delivery nano-Systems; ITC; Isothermal Titration Calorimetry; DOX; doxorubicin; Lactobacillus helveticus; L. helveticus; Doxorubicin; Drug delivery; Liposomes; Dendrimers; Isothermal titration calorimetry (ITC); Lactobaci
Functionalized hBN as targeted photothermal chemotherapy for complete eradication of cancer cells
Keywords: دوکسوروبیسین; Photothermal therapy; Chemotherapy; Hyaluronic acid; Doxorubicin; ICG; hBN;
Hesperetin-etoposide combinations induce cytotoxicity in U2OS cells: Implications on therapeutic developments for osteosarcoma
Keywords: دوکسوروبیسین; Hesperetin (PubChem CID: 72281); Etoposide (PubChem CID: 36462); Doxorubicin (PubChem: 32874); CV; crystal violet; DMSO; dimethyl sulfoxide; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Hesperetin; Etoposide; Doxorubicin; Cell cycle;
Immediate Hypersensitivity Reaction to Chemotherapeutic Agents
Keywords: دوکسوروبیسین; Hypersensitivity reactions; Chemotherapeutic agents; Anticancer drugs; Anaphylaxis; Cancer; Adverse drug reactions; Desensitization; Platinum-based agents; Taxanes; Doxorubicin; BAT; Basophil activation test; HR; Hypersensitivity reaction; IHR; Immediate
AKR1B10-inhibitory Selaginella tamariscina extract and amentoflavone decrease the growth of A549 human lung cancer cells in vitro and in vivo
Keywords: دوکسوروبیسین; Amentoflavone (PubChem CID: 5281600); Doxorubicin hydrochloride (PubChem CID: 443939); Epalrestat (PubChem CID: 1549120); AKR1B10; Amentoflavone; Anti-cancer; Combinatorial treatment; Doxorubicin; Selanginella tamariscina;
Potential effects of gamma irradiation on the stability and therapeutic activity of anticancer drug, doxorubicin
Keywords: دوکسوروبیسین; Radiotherapy; Chemotherapy; Gamma radiation; Doxorubicin; Overlapping; Stability of anticancer drug;
Germ cell responses to doxorubicin exposure in vitro
Keywords: دوکسوروبیسین; DNA damage; Apoptosis; Doxorubicin; Comet assay; TUNEL assay; Male germ cells;
Functionalized nanoparticles enable tracking the rapid entry and release of doxorubicin in human pancreatic cancer cells
Keywords: دوکسوروبیسین; Pancreatic cancer; SPIO nano particles; Drug delivery; Doxorubicin;
Original ArticleDoxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells
Keywords: دوکسوروبیسین; Edelfosine; Doxorubicin; Lipid nanoparticles; Osteosarcoma; Synergy; Metastases; DOX; doxorubicin; CI; Combination index; DRI; drug reduction index; ET; Edelfosine; Fa; Fraction of affected cells; IC50; inhibitory concentration 50; LN; lipid nanoparticles
Exceptionally high UBE2C expression is a unique phenomenon in basal-like type breast cancer and is regulated by BRCA1
Keywords: دوکسوروبیسین; UBE2C; ubiquitin-conjugating enzyme 2C; BBC; basal-like breast cancer; HR; hazard ratio; P-gp; P-glycoprotein; MRP1; multidrug resistance protein 1; BCRP; breast cancer resistance protein; SD; standard deviation; Breast cancer; UBE2C; BRCA1; Doxorubicin;
Facile preparation of pH/reduction dual-responsive prodrug microspheres with high drug content for tumor intracellular triggered release of DOX
Keywords: دوکسوروبیسین; Prodrug microspheres; High drug content; pH/reduction dual-responsive; Tumor intracellular triggered release; Doxorubicin;
Doxorubicin-loaded micelles of amphiphilic diblock copolymer with pendant dendron improve antitumor efficacy: In vitro and in vivo studies
Keywords: دوکسوروبیسین; Diblock copolymer micelles; Doxorubicin; Anticancer; Drug delivery; Biodistribution;
Preparation of dual responsive low-molecular-weight hydrogel for long-lasting drug delivery
Keywords: دوکسوروبیسین; Low-molecular-weight hydrogel; Glucose-responsive; pH-responsive; Long-lasting drug delivery; Phenformin; Doxorubicin;
Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release
Keywords: دوکسوروبیسین; Mesoporous silica nanoparticles; Thermo-responsive release; Supported lipid bilayer; Doxorubicin; Drug delivery;